Stack · Promising

BPC-157 + GHK-Cu + Arimistane

Balance estrogen rebound after cycle cessation BPC-157 250 mcg/day oral; GHK-Cu 100 mcg/day; Arimistane 25-50 mg/day (short term)

Last updated · Mon Apr 27
Promising

Reasonable pairing with mechanistic rationale; widely used in community protocols.

Buy this stack

Cheapest Split $76.49 across 2 vendors
CompoundVendorSizePrice
BPC-157 Particle Peptides 5 mg $31.99
GHK-Cu Verified Peptides 100 mg $44.50

Missing vendor data for: Arimistane

Components

BPC-157

Upregulates growth hormone receptors, modulates nitric oxide system (NO/NOS), promotes angiogenesis, activates FAK-paxillin pathway, modulates dopaminergic and serotonergic systems

Half-life: ~4 hours (stable in gastric juice — unique among peptides)

GHK-Cu

Copper-binding tripeptide that activates tissue remodeling, collagen/elastin synthesis, anti-inflammatory gene expression, DNA repair, and stem cell recruitment. Resets expression of 4,000+ genes toward a younger profile.

Half-life: ~1 hour (injectable); variable topical absorption

Arimistane

Compound page not yet published

Estrogen Reset

Balance estrogen rebound after cycle cessation

Dosing notes

BPC-157 250 mcg/day oral; GHK-Cu 100 mcg/day; Arimistane 25-50 mg/day (short term)